News Oxford Nanopore Technologies plc

Equities

ONT

GB00BP6S8Z30

Advanced Medical Equipment & Technology

Market Closed - London S.E. Other stock markets 16:35:23 18/11/2025 GMT			5-day change	1st Jan Change
123.60 ^GBX	-3.21%		-10.50%	-4.04%

11-07	FTSE 100 held back by hefty Rightmove, IAG falls	AN
11-07	Oxford Nanopore Technologies Sees FY25 Revenue Growth at Top End of Guidance Range	MT

FTSE 100 held back by hefty Rightmove, IAG falls	11-07	AN
Oxford Nanopore Technologies Sees FY25 Revenue Growth at Top End of Guidance Range	11-07	MT
Oxford Nanopore shares up as expects annual growth at top end of range	11-07	AN
Oxford Nanopore Technologies expects 2025 revenue growth at top end of guidance	11-07	RE
Oxford Nanopore Technologies plc Reaffirms Earning Guidance for the Full Year 2025	11-07	CI
Oxford Nanopore and bioMérieux launch AmPORE-TB, a Research Use Only sequencing-based solution to rapidly characterize drug resistant-tuberculosis	11-05	CI
BioMérieux: launches solution to identify antibiotic-resistant tuberculosis	11-05
Novogene Expands UK Offerings with Launch of ONT-Based Whole Plasmid Sequencing Service	11-05	CI
UK government confirms GBP55 billion boost for science and tech R&D	10-30	AN
Oxford Nanopore Technologies Announces PromethION Plus Flow Cell and Human Genetics Updates At ASHG 2025	10-15	CI
Bio-Techne Corporation and Oxford Nanopore Technologies Expand Agreement to Accelerate Development of Genetics Portfolio Through 2032	10-09	CI
Bio-Techne and Oxford Nanopore Technologies Expand Agreement to Accelerate Development of Genetics Portfolio Through 2032	10-09	PR
IP Group halves interim loss, eyes GBP250 million exits by 2027	09-17	AN
Compass raised; Hays and Ashtead cut	09-11	AN
RBC Raises Oxford Nanopore Price Target as Losses Narrow	09-08	MT
Citigroup raises Marks & Spencer to 'buy'	09-08	AN
Morgan Stanley lifts BP; Investec cuts Domino's	09-03	AN
Berenberg Stays Bullish on Oxford Nanopore Technologies After Lower H1 Losses	09-02	MT
Oxford Nanopore Technologies plc, H1 2025 Earnings Call, Sep 02, 2025	09-02
Oxford Nanopore Technologies plc Reports Earnings Results for the Half Year Ended June 30, 2025	09-02	CI
Europe mixed as gold climbs amid US uncertainty	09-02	AN
Oxford Nanopore loss narrows, despite reduced margin, on buoyant sales	09-02	AN
Oxford Nanopore loss narrows; Uniphar profit improves	09-02	AN
Oxford Nanopore Technologies Posts Narrower H1 Loss; Revenue Up	09-02	MT
Oxford Nanopore Technologies : Interim results for the 6 months ended 30 June 25	09-02	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Oxford Nanopore Technologies plc

Equities

ONT

GB00BP6S8Z30

Advanced Medical Equipment & Technology

Filters